Navigation Links
Dispensing 0.5μL to "Dry" 384 Plates with the Sciclone ALH

act of the cannulas with the plates is required when transferring sub-microliter volumes to dry plates, potentially resulting in variable %CV's (unpublished data). For the above results, we used a shorter, finer 384/1536 Cannula Array designed for accessing 384 well plates or 1536 plates (by dispensing into four quadrants). This type of a cannula array can fully access standard microplates, or half height deep well plates. The main benefit of the smaller cannulas is that uniform droplets can form on the ends of the finer cannulas, allowing the dispense of the droplet onto the plate without contacting the plate.

The success of dry dispensing depends on assuring the Cannula Array and destination plates are parallel. Therefore, it is necessary to level any position in which sub-microliter dry dispensing is attempted. The deck of the Sciclone ALH is designed to be adjustable at each corner. The individual plate locators must also be level. It is also necessary to determine a precise dispense height for any non-contact dispense operation.

Physical factors are an important determinant of overall dispensing performance. Such factors include microplate composition, microplate surface treatments, solvent concentrations and compositions, solute (compound) characteristics and solute concentration. The current study represents 2.8g/L tartrazine dissolved with DMSO and dispensed into untreated, flat-bottomed, polystyrene plates only. Under these conditions we demonstrated that it is feasible to dispense sub microliter volumes to dry plates with very good precision.


'"/>

Source:


Page: All 1 2 3

Related biology technology :

1. Counting Colonies or Plaques Directly from Images of Agar Plates
2. Counting FlashPlates on the Wallac MicroBeta
3. Direct Counting of Millipore MultiScreen Filtration Plates.
4. Sciclone ALH Bulk Dispense Precision Testing
5. 96 Well Pipetting Precision Testing Using the Sciclone ALH with a 384 Fixed-Cannula Array
6. Sciclone ALH 3000 Liquid Handler: Functional Characterization of the High Volume Head - Part 1: Plate-to-Plate Precision Testing
7. Scalable Automation of the TempliPhi DNA Sequencing Template Amplification and DYEnamic ET Terminator Sequencing Kits on the Sciclone ALH 3000
8. Precision Testing for the Sciclone Advanced Liquid Handler Z8 Option
9. 384 Well Pipetting Precision and Accuracy Testing Using the Sciclone Advanced Liquid Handler
10. Automation of the Eppendorf Perfectprep BAC 96 DNA Kit on the Caliper Life Sciences Sciclone ALH 3000
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Dispensing Dry Plates with the Sciclone ALH

(Date:7/29/2015)... , July 29, 2015 /PRNewswire/ - RepliCel Life ... stage regenerative medicine company, is pleased to announce that ... injector (RCI-02) have been locked.  Prototypes for industrial ... prepare for an application for CE mark clearance ... in 2016. (Photo: ...
(Date:7/29/2015)... San Bruno, CA. (PRWEB) , ... July 29, ... ... partnership agreement with PRC Clinical, a Silicon Valley-based CRO specializing in ... FDA advisory services, and patient recruitment services. The core expertise of PRC Clinical ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... ... Industries’ (BI) advanced cell culture products, announces the availability of BI’s line of ... by Biological Industries, these stem cell differentiation media offer a complete system for ...
(Date:7/28/2015)... A n ... rapidly developing and commercialising innovative medicines to transform patient quality ... Highly experienced management team; blue chip ... Mereo BioPharma Group Ltd ("Mereo"), a recently-formed speciality biopharmaceutical company, ... £76.5m), gross, from blue chip institutional investors and simultaneously acquired ...
Breaking Biology Technology:RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 2RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 3RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 4RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 5CSSi LifeSciences And PRC Clinical Join Forces To Offer Extended Clinical Trial Services 2CSSi LifeSciences And PRC Clinical Join Forces To Offer Extended Clinical Trial Services 3Rainbow Scientific, Inc. Announces Availability of Human Mesenchymal Stem Cell Differentiation Media 2Rainbow Scientific, Inc. Announces Availability of Human Mesenchymal Stem Cell Differentiation Media 3Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 2Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 3Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 4Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 5Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 6Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 7Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 8Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 9Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 10Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 11
... , MOUNTAIN VIEW, ... Partnership Company, honored healthcare companies for demonstrating leadership and ... Healthcare Innovation Awards Banquet held in San Antonio, Texas. ... Innovation Awards are given to companies that have made ...
... , CARY, N.C., Nov. 23 Cornerstone Therapeutics Inc. ... acquiring, developing and commercializing significant products primarily for the respiratory ... and Chief Executive Officer, will be presenting a corporate overview ... 3:30 PM ET on Wednesday, December 2, 2009 at The ...
... an opportunity to take the lead in two small ... working together with the IDICHUS Foundation, have studied the ... is that Spain,s food and plant sectors have more ... applied to food and plants has been overlooked by ...
Cached Biology Technology:Excellence in Healthcare Innovation Recognized by Frost & Sullivan 2Excellence in Healthcare Innovation Recognized by Frost & Sullivan 3Cornerstone Therapeutics to Present at the 21st Annual Piper Jaffray Health Care Conference 2Cornerstone Therapeutics to Present at the 21st Annual Piper Jaffray Health Care Conference 3Spanish biotechnology should focus on food and plant sectors to be more competitive 2
(Date:7/8/2015)... YORK , July 8, 2015 Summary ... globally, and the fourth most fatal, with a mortality ... The poor prognosis of pancreatic cancer patients has highlighted ... treatment, which is not being met by the current ... an array of products with varying molecule types and ...
(Date:7/7/2015)... June 30, 2015 ... the addition of the "Capacitive Fingerprint Sensors ... To this date, fingerprint sensing technology is ... fingerprint sensors are well developed. This patent landscape ... The domain of capacitive fingerprint sensors ...
(Date:7/2/2015)... 25, 2015 Research and ... "Next Generation Biometrics Market by Application, Technology, Function ... to their offering. The next generation biometrics ... at a CAGR of 17.9% between 2015 and 2020 ... for the market. Safran SA ( ...
Breaking Biology News(10 mins):Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 3
... habitats where light may be a limiting factor. In ... (lacking chlorophyll), as well as green, orchids depend on ... in order to grow. However, orchids are found in ... photosynthetic capabilities. For those orchids that are fully ...
... Clearwater Beach, FL. Research to be presented at ... Study of Ingestive Behavior (SSIB), the foremost society for ... suggests that people can become dependent on highly palatable ... similar to the behaviors we observe in drug addicts ...
... Vegetation in towns and cities can make a significant ... even more carbon if local authorities and gardeners planted and ... British Ecological Society,s Journal of Applied Ecology , is ... vegetation within an urban area of Europe. Using satellite ...
Cached Biology News:Orchids and fungi: An unexpected case of symbiosis 2Orchids and fungi: An unexpected case of symbiosis 3Orchids and fungi: An unexpected case of symbiosis 4Evidence for 'food addiction' in humans 2Plants in cities are an underestimated carbon store 2
Human/Mouse G9a/EHMT2 MAb (Clone A8620A) Keywords: Eu-HMTase2...
Mouse GDF-8 Propeptide Affinity Purified Polyclonal Ab...
SRY (sex determining region Y)-box 10...
Normal human serum, single donor...
Biology Products: